Shell Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Shell Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,038	Closed	-$541K	–	1141
2017 Q4	$541K	Hold	10,038	–	–	0.01%	881
2017 Q3	$573K	Buy	+10,038	New	+$588K	0.01%	816
2017 Q2	–	Sell	-1,066	Closed	-$58K	–	1091
2017 Q1	$58K	Buy	+1,066	New	+$52.5K	﹤0.01%	1070

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Shell Asset Management's BIVV Position: Q1 2018 in Review

Shell Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 10,038 shares — an estimated $541K sold.

Shell Asset Management first reported a position in BIVV in Q1 2017 and held it in 3 quarters. The position peaked at $573K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Shell Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Shell Asset Management sold 10,038 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $541K.
Shell Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 3 quarters.
Shell Asset Management's Bioverativ Inc. Common Stock position peaked at $573K in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Shell Asset Management's 13F filing for Q1 2018, filed 14 May 2018.